U.S. markets open in 6 hours

ObsEva SA (OBSV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.9000+0.0100 (+0.26%)
At close: 4:00PM EST
Sign in to post a message.
  • R
    R
    @Tuna_Taster you're post is a breath of fresh air. So many gamblers. It's decent in this one comparatively. Try DVAX. The stock was up 7%+ on Friday, up 38%+ for the month of Feb. Nearly all posts were from disappointment to accusations of market manipulation to fraud because of the disappointing stock price. Plethora of name-calling. You know, like third graders. Perhaps they are? I've been investing for 50+ years. Love small biotechs. It requires patience and research. So many don't understand how the markets actually function. I'm still amazed that with the dramatic selloff a year ago didn't crash the infrastructure. From my past experience a good correction cleans out the gamblers. In all honesty creates incredible clearance sales! Also, hurts my statements for a short period. Just the price one pays. ... perhaps a correction will coincide with reopening of casinos and tracks?
    Bullish
  • C
    Case
    If you listen to the presentation this morning there were some news items in there. The pipeline is progressing as previously presented. not much news. Brian did say they were in a much better financial position and they are in active negotiation with several partners. Both big companies and specialty companies. They are focused on picking the right company that has the ability to maximize availability the treatments and bring it to as many people as possible with the proper education for providers. That all made sense to me. What was new was he said they were close to a decision who they are going to be selecting as partners. So the main two reasons why the stock is so cheap are now no longer valid. We are close finding a partner and we have the money to work the plan. Now lets go up to fair value today $12-$18. Next year $20-$30. Good luck longs.
    Bullish
  • A
    Achalm
    At what point should bios show resistance. So far the nasdaq is down about 4-5% and all of my bios are down around 30-40%. My theory is that small companies react early and then break free from the overall market trend. Would anyone say this could be the case?
  • C
    Corby
    Again if one has patience this stock will pay back handsomely. They have too many impressive products. Just hold and have faith
  • C
    Case
    All the reasons the stock was depressed have been taken out. We no longer have a cash problem. We have partners to choose from. We also have best in class no hormone options for treatment with zero side effects. That means we can treat all women that need it .It gives us a huge advantage over the competition who can only serve 50% with one size fits all. There is no more reason to keep us down unless you want to buy it cheaper and are manipulating the price down. We all saw that happen last year. Good luck
  • C
    Case
    Having all the heavy hitters of the board of directors on the call yesterday but not Ernest threw me off yesterday. I previously thought Ernest got played by potential buyers last year with low offers that he could not get behind. You have to realize that we spent close to 500 million dollars on our pipeline since 2012. Now that we have our first drug ready for approval any offer below that investment is not acceptable. I think this was a show for the buyers that whatever Ernest told them last year no longer applies.
    There is a new sherif and he has the board behind him.
    All good for us shareholders.
  • t
    tawfik
    ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference



    Company Management will be participating at the SVB Leerink 10th Annual Global Healthcare Conference taking place February 23 – 25, 2021

    ObsEva will present on Wednesday, February 24, 2021 at 8:40 a.m. Eastern Time (ET).
  • R
    R
    Let's see. Stock price is up ~33% in a few days? Horrid! If you're expecting stock to move up every day forever, I'd suggest selling. So, small biotech is a category I follow. Looking at 8 stocks, all were down between 3%-7%. It might be a macro move. Tech had a tough day. If you buy short dated calls, get used to it. Quants computers get excited and scream into the dark. Private money managers cash out after a big run. Important watch: is stock going to make higher lows and higher highs?
    Bullish
  • C
    Case
    It is never easy to watch a stock gets beaten down that does not deserve it.
    I think this is short lived and we will bounce right back to new highs after earnings next week. Weak hands will be gone with the cycles we always get in this space. That is why I only go long with undervalued stocks that have bright futures. ACRX is another one like this. Day trading is for gamblers. No thank you.
  • C
    Case
    The bears are having another
    stab at us but they only have a few days to get their way. As soon as we get conformation the balance sheet got fixed there is no more time left for the manipulation. We should go up considerably.
  • 🎩 Oz
    I wouldn't worry about today. Almost all stocks got smoked. We'll come back.
  • u
    unknown
    In order for this to become an actual tangible investment and tangible pipeline we need MAA approval and cash on hand! Let’s be realistic as of this moment this all talk with just 3 medical trails. Been here long enough to realize now internal management is doing their pumps and dumps after each presentation!!!
  • C
    Christian
    This moves every monthly options expiry. No relevant news before end Q2 (May-June).

    March options date (17 March) will be a down event likely, as March is retraction date f or biotech, year after year after year .... after options expiry.

    Hence, buy at 3.40 or lower mid end of March, this is my plan at least. Will it teach 6-12 USD before .. well why ? All news do ye that is out since end Jan ... and it did not hap power n Option expiry dates spikes only Jan and Feb ... up ... Match will be down as overly positive retail investors .... and again .... zero news until May / June.

    Buy later, buy lower, far lower with correction in March / April, far far lower IMO.
    Neutral
  • R
    R
    If you're holding your breath on each tick each day, this company might not be suitable for your investment style. Lots going for it. But it has to play out over a year or two. I invested in EDIT a few years ago. $14.33. Bounced wildly. Patience paid off. Sold in autumn 20 @ 72.71. Still doesn't have approved treatment. Pharma, especially biotech, isn't for immediate gratification. Even Pfizer wrote off $962 million around 2005 for a Lipitor replacement. Phase III results inconsequential.
    Bullish
  • C
    Cheri
    Big conference tomorrow Institutional buyers fishing for cheap shares will bounce back higher !!
    Bullish
  • C
    CCN
    Great day for OBSV! Trading volume was 3X more than average. Next week will be very interesting...let’s hope the volume and stock price will continue to advance for a few more days...
  • R
    R
    Spot on @Case . All shorts, being puts or calls. Too many short term calls. Is Aqueduct parimutuel window closed? I don't care about the next tick on the tape. OBSV has a promising pipeline. In biotech that's most important. I've been a student of pharma/biotech for decades. Hate to admit taking advantage of others' misery. But, scooped up more shares in last hour. Not at absolute lows. But, nice price.
    Bullish
  • P
    PELOSIPHOBIC
    Medicxi Capital adding... All eyes turning toward OBSV in pharma Something is about to break? Similar thing is happening in SENS, but more Robinhood driven. Watch and see...
    Bullish
  • J
    Jesse
    whats everyones biggest stock bets currently? mine is SENS and OBSV. I got into OBSV today with $18K worth, hoping it pays off.
    Bullish
  • J
    Jerk
    Don’t sell before the conference Wednesday. After the presentation the stock could really go up